-
EP1859024
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1859024
| EP1859024 - METHOD OF PROVIDING READILY AVAILABLE CELLULAR MATERIAL DERIVED FROM CORD BLOOD, AND A COMPOSITION THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 01.04.2011 Database last updated on 02.11.2024 | Most recent event Tooltip | 01.04.2011 | Application deemed to be withdrawn | published on 04.05.2011 [2011/18] | Applicant(s) | For all designated states Regenetech, Inc. 3102 Shawnee Drive Sugar Land, TX 77479 / US | [2007/48] | Inventor(s) | 01 /
RUDD, Donnie 1323 Creekford Circle Sugar Land, Texas 77478 / US | [2007/48] | Representative(s) | Ebner von Eschenbach, Jennifer, et al Ladas & Parry LLP Dachauerstrasse 37 80335 München / DE | [N/P] |
| Former [2008/39] | Ebner von Eschenbach, Jennifer, et al Ladas & Parry LLP Dachauerstrasse 37 80335 München / DE | ||
| Former [2007/48] | Ebner von Eschenbach, Jennifer, et al Ladas & Parry LLP Dachauerstrasse 37 80335 München / DE | Application number, filing date | 06719703.8 | 26.01.2006 | [2007/48] | WO2006US02961 | Priority number, date | US20050647588P | 27.01.2005 Original published format: US 647588 P | [2007/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2006081435 | Date: | 03.08.2006 | Language: | EN | [2006/31] | Type: | A2 Application without search report | No.: | EP1859024 | Date: | 28.11.2007 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.08.2006 takes the place of the publication of the European patent application. | [2007/48] | Search report(s) | International search report - published on: | EP | 08.03.2007 | Classification | IPC: | C12N5/02 | [2007/48] | CPC: |
A01N1/02 (EP,US);
C12N5/0647 (EP,KR,US);
A01N1/0221 (EP,US);
A61K35/51 (EP,US);
A61K38/193 (EP,US);
A61K41/0052 (EP,US);
A61P1/00 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P17/00 (EP);
A61P19/00 (EP);
A61P19/08 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P7/00 (EP);
A61P9/00 (EP);
C12M27/10 (EP,US);
| C-Set: |
A61K35/51, A61K2300/00 (EP,US);
A61K38/193, A61K2300/00 (US,EP) | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2007/48] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | VERFAHREN ZUR BEREITSTELLUNG VON VERFÜGBAREM ZELLMATERIAL AUS NABELSCHNURBLUT UND ZUSAMMENSETZUNG DARAUS | [2007/48] | English: | METHOD OF PROVIDING READILY AVAILABLE CELLULAR MATERIAL DERIVED FROM CORD BLOOD, AND A COMPOSITION THEREOF | [2007/48] | French: | PROCEDE D'OBTENTION DE MATERIAU CELLULAIRE DERIVE DE SANG DE CORDON FACILEMENT UTILISABLE, ET COMPOSITIONS CORRESPONDANTES | [2007/48] | Entry into regional phase | 22.08.2007 | National basic fee paid | 22.08.2007 | Designation fee(s) paid | 22.08.2007 | Examination fee paid | Examination procedure | 20.07.2007 | Amendment by applicant (claims and/or description) | 22.08.2007 | Examination requested [2007/48] | 29.04.2010 | Despatch of a communication from the examining division (Time limit: M06) | 10.11.2010 | Application deemed to be withdrawn, date of legal effect [2011/18] | 14.12.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/18] | Fees paid | Renewal fee | 22.08.2007 | Renewal fee patent year 03 | 31.07.2009 | Renewal fee patent year 04 | 27.01.2010 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 31.01.2009 | 04 M06 Fee paid on 31.07.2009 | 31.01.2011 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||